The objective of this study is to gain better inside in decision-making in the treatment of mood and anxiety disorders and treatment preferences of both patients and clinicians. We will explore factors that determine decisions and look for possible…
ID
Source
Brief title
Condition
- Other condition
- Mood disorders and disturbances NEC
Synonym
Health condition
+ angststoornissen- en symptomen
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
In the third stage of this study the following study parameters will be used to
evaluate the newly developed decision aid:
- Shared Decision Making, measured by the SDM-Q-9 (Shared Decision Making
Questionaire)
- Decisional Conflict, measured by the DCS (Decisional Conflict Scale)
These parameters will be used to assess the effect of the decision aid on
decison-making, by comparing the scores on these scales from patients and
clinicians who used the decision aid, to scores of those who did not use it,
measured in a earlier stage of the study.
Secondary outcome
nvt
Background summary
The 'Treatment Preferences and Decision-Making in Mental Health' study focuses
on prefences and decision-making in the treatment of mood- and anxiety
disorders. These disorders belong to the most prevalent disorders in the
Netherlands, they cause a significant burden of desease and high costs. Known
effective treatments are psychofarmaca or psychotherapy, the choice of one of
these therapies depends on the illness and treatment guidelines. Yet there are
other factors that influence these decisions, for example the personal
preferences of patiënts and clinicians (psychiatrists and psychologists). The
last few years the importence of patient centered care and patient involvement
in decision-making is emphasized by the medical world. With that there has been
a growing interest in treatment preferences of patients. Patients want to be
more actively involved in medical decisions. Shared Decison-Making could
accomplish this. Despite the fact that the research on SDM in Mental Health
Care is clearly behind compared to other areas of medicine, SDM seems to have a
role to play in psychiatry too. More knowledge of preferences, their role and
the role of other factors in the decision-making proces can improve
decision-making in mental health care practice and enhance the quality of care.
Study objective
The objective of this study is to gain better inside in decision-making in the
treatment of mood and anxiety disorders and treatment preferences of both
patients and clinicians. We will explore factors that determine decisions and
look for possible differences with regard to these factors between patients
with different disorders. In addition personal experiences and needs relating
to (shared) decision-making in clinical pratice will be investigated. This
researchproject aims to use this information to develop a practical decision
aid, which will facilitate and improve decision-making in the treatment of mood
and anxiety disorders.
Study design
This observational study consists of three stages and uses both quantitative
and qualitative research methods.
Stage I (qualitative), seven focusgroups, made up of patients or psychiatrists,
will be used to discuss preferences, different aspects of decision-making and
important factors that determine specific choices. The groups shall be composed
of: 1. Patients with an anxiety disorder; 2. Patients with a mood disorder. 3;
Patients with an obsessive-compulsive disorder; 4./5. Psychiatrists of GGZ
Rivierduinen; 6. Psychiatrists of LUMC Psychiatric Department and 7.
Psychiatrists of the NedKAD 8. Clinical Psychologists of GGZ-Rivierduinen
Stage II (quantitative), the qualitative data will be used to conduct a cross
sectional survey, to measure these factors and other aspects of
decision-making. The required sample size for this study is estimated to be
N=145 psychiatrists/psychologists and N=200 patients. Relevant information from
ROM- measurements (Routine Outcome Monitoring) will be used to supplement the
patients data.
Stage III, all collected data is used to develop a practical decision aid,
which will be implemented and evaluated on a small scale with semi-structured
interviews. For this feasibility study we will ask 20 patients and clinicians
to participate.
Study burden and risks
Ethical aspects: The burden and risks associated with participation in this
study will be kept to the minimum.
Focusgroup meetings take place at a convenient time and place and will take 1,5
to 2 hours.
Filling in the questionaires will take no longer than 15 minutes. Since
ROM-measurements and therefore completing questionaires are part of the
standard diagnostic and treatment procedure of GGZ Rivierduinen/ LUMC
Psychiatric Department, participation will not bring any extra risks and the
burden for patients participating in this study is minimal. Obtained data will
be rendered anonymous to protect the privacy of participants.
Patients will be well informed about the study and asked to sign an informed
consent before participating. They will be given one or two weeks to consider
participating in this study. Participants are also informed that they have the
right to withdraw from participation at any time and without reason during the
study. This will not affect future treatment at Rivierduinen/ LUMC.
Albinusdreef 2
Leiden 2333ZA
NL
Albinusdreef 2
Leiden 2333ZA
NL
Listed location countries
Age
Inclusion criteria
Patients:
1. Sufficient proficiency in the Dutch language.
2. Age between 21 and 65 years.
3. Diagnosed with one or more mood and/or anxiety disorders.
4. Newly registered or recently under treatment for one or more mood and/or anxiety disorders;Clinicins
1. Employed as mental health practitioner by GGZ Rivierduinen or LUMC Psychiatric Department.
2. Licensed Psychiatrist (or resident) or clinical psychologist.
3. Experience with decision-making in the treatment of mood and anxiety disorders.
Exclusion criteria
Patients:
1. Presence of manic and/or psychotic symptoms.
2. Other comorbid problems in the foreground (neurological, personality or addiction problems; suicidal tendency).
3. Severe social dysfunctioning (disabling the patient to come to appointments or a focus group meeting).
4. Participation not desirable in opion of the clinician, because of the severity of the patients illness and/or the burden of participating.
Design
Recruitment
metc-ldd@lumc.nl
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL39043.058.11 |